[Acute viral myocarditis. 2: Therapy].
The treatment of viral myocarditis continues to present problems. To date, no specific therapy has become available. Relevant studies performed so far have been open, uncontrolled or randomized, the numbers of patients small, and the patient groups highly inhomogeneous. Furthermore, diagnostic and evolution criteria have differed considerably. Since the results of these studies are inconsistent, and it has so far not proved possible to demonstrate a positive long-term effect of immunosuppressive treatment, general use of immunosuppressive therapy cannot at present be recommended. Before the final word can be spoken on this, we shall have to await the results of numerous ongoing therapeutic studies.
Schultheiss
H P
HP
Abteilung für Kardiologie, Pneumologie und Angiologie, Universität Düsseldorf.
D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009205:Myocarditis / Q000188:drug therapy*; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D007166:Immunosuppressive Agents